Search
for
Sort by
Research 61–90 of 1000+
- TRPV3 as a Therapeutic Target for Itch
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Comparison of finasteride versus flutamide in the treatment of hirsutism
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- A current review of the cutaneous manifestations of renal disease
- Clinical development and management of adverse events associated with FGFR inhibitors
- Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis
- Sjögren's Syndrome in Scurvy
- 9-cis-Retinoic Acid Capsules in the Treatment of AIDS-Related Kaposi Sarcoma
- Care of the newborn with ichthyosis
- Gefitinib: an adverse effects profile
- Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of the COVID ‐19 pandemic
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Keratosis follicularis spinulosa decalvans: a family study of seven male cases and six female carriers.
- Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome
- Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area
- Molecular characterization of xerosis cutis: A systematic review
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- Changes in dermatological complaints among healthcare professionals during the COVID-19 outbreak in Turkey
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia
- Essential Thrombocythemia: The Dermatologic Point of View
- Mucocutaneous manifestations of acquired hypoparathyroidism: An observational study
- Dermatologists’ perceptions on the utility and limitations of teledermatology after examining 55,000 lesions
- Public interest in dermatologic symptoms, conditions, treatments, and procedures during the COVID‐19 pandemic: Insights from Google Trends
- Molecular Genetics of Keratinization Disorders – What’s New About Ichthyosis
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- Cutaneous features of myotonic dystrophy types 1 and 2: Implication of premature aging and vitamin D homeostasis
- Rash from EGFR inhibitors: Opportunities and challenges for palliation